SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as gold prices reach new all-time highs, fueled by trade tensions and expectations of dovish moves by the Federal Reserve. The community is actively debating whether gold's surge signals broader economic instability or if it's entering bubble territory, with some comparing it to Bitcoin's volatility. Discussions also revolve around potential pullbacks, profit-taking strategies, and the impact of central bank activity and global events.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending amidst discussions around potential market distribution near all-time highs and reactions to political news. Community members are debating the significance of high daily volumes and whether a significant market correction is imminent. Some traders are expressing concern over recent price action, while others remain bullish, anticipating a rally.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

PRAX is trending due to significant volatility following positive Phase 3 trial results for its essential tremor treatment, though some analysts are tempering expectations. Community discussions revolve around profit-taking strategies, short selling opportunities, and potential dilution. Several traders are pointing to other bio stocks to watch.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending due to takeover speculation, with Datadog reportedly exploring a fresh bid. The community is debating the potential deal's value, with some shareholders believing the company is worth significantly more. Meanwhile, some traders express skepticism about the long-term potential of the stock, regardless of takeover news.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

Interactive Brokers is trending following a strong earnings report, with discussions focusing on the company's growth in customer accounts and trading activity. Community members are weighing the impact of potential interest rate cuts on future earnings, while analysts are raising price targets. Some traders believe the stock is undervalued and poised for further gains, while others note potential headwinds.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors (SEV) is trending following its direct listing, marked by significant volatility and trading halts. The community is actively debating the company's prospects, its unique solar EV technology, and comparing it to other EV plays. Discussions also include the potential for short squeezes and long-term viability.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF ($GDX) is trending upwards, driven by factors such as US-China trade tensions and speculation around potential Federal Reserve rate cuts, pushing gold prices to new all-time highs. Community members are actively discussing whether to load up on call options or take profits, with some pointing to technical indicators suggesting the ETF is overbought. Broader discussions include the potential for gold to reach new price targets amid global economic uncertainty and dollar devaluation.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending downwards as the community discusses legal challenges in the UK related to talc and recent comments linking Tylenol to autism, despite denials from the company and experts. Community members are debating the impact of potential liabilities and the company's valuation, while also pointing to large options positions, potential bottom fishing opportunities, and speculation around management's response. Some traders express a long-term bullish outlook, emphasizing Kenvue's strong brand portfolio and dividend.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending due to recent volatility and speculation around potential government investment in rare earth minerals, driven by renewed focus on domestic supply chains. The community is actively discussing the stock's price swings, potential short squeezes, and the impact of European Lithium's (EULIF) stake in the company. Many are also closely watching for news related to President Trump's upcoming meeting with the Australian Prime Minister, which could involve critical minerals discussions.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences N.V.

ATAI Life Sciences is trending due to positive Phase 2a clinical trial results for BPL-003, a treatment for resistant depression, with discussions centering on its potential for FDA approval and market impact. Community members are weighing the implications of a proposed public offering amidst the positive news, with some viewing it as a buying opportunity after the initial volatility. The stock is also gaining attention as part of a broader sector movement towards psychedelic-assisted therapies for mental health.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide

The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen...

SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?

Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.

Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top

HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.

Henry Schein (HSIC) Q2 Earnings Lag Estimates

Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein to Report Q2 Earnings: What's in Store for the Stock?

HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.

Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

HSIC
Henry Schein Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HSIC News

HSICHenry Schein Inc.